Shinichi Kako

3.9k total citations
178 papers, 1.9k citations indexed

About

Shinichi Kako is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shinichi Kako has authored 178 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Hematology, 56 papers in Oncology and 49 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shinichi Kako's work include Hematopoietic Stem Cell Transplantation (97 papers), Acute Lymphoblastic Leukemia research (44 papers) and Acute Myeloid Leukemia Research (34 papers). Shinichi Kako is often cited by papers focused on Hematopoietic Stem Cell Transplantation (97 papers), Acute Lymphoblastic Leukemia research (44 papers) and Acute Myeloid Leukemia Research (34 papers). Shinichi Kako collaborates with scholars based in Japan, United States and Ireland. Shinichi Kako's co-authors include Yoshinobu Kanda, Hideki Nakasone, Takahiro Fukuda, Miki Sato, Koji Izutsu, Mineo Kurokawa, Rie Yamazaki, Junji Nishida, Misato Kikuchi and Kumi Oshima and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Shinichi Kako

164 papers receiving 1.9k citations

Peers

Countries citing papers authored by Shinichi Kako

Since Specialization

Citations

This map shows the geographic impact of Shinichi Kako's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinichi Kako with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinichi Kako more than expected).

Fields of papers citing papers by Shinichi Kako

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinichi Kako. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinichi Kako. The network helps show where Shinichi Kako may publish in the future.

Co-authorship network of co-authors of Shinichi Kako

This figure shows the co-authorship network connecting the top 25 collaborators of Shinichi Kako. A scholar is included among the top collaborators of Shinichi Kako based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinichi Kako. Shinichi Kako is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma 2024 ·Bone Marrow Transplantation ·(unknown), Hirohisa Nakamae, (unknown), Eisei Kondo, Takahiro Fukuda, Nobuhiro Hiramoto, Yasuo Mori, Koji Nagafuji, Tetsuya Eto, Yasushi Onishi, Naoyuki Uchida, Jun Ishikawa, Ken‐ichi Matsuoka, Shunsuke Yui, Ken Takase, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako	1
2	Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents 2024 ·Blood ·Hiroaki Shimizu, Yuho Najima, Shinichi Kako, Takayoshi Tachibana, (unknown), (unknown), Emiko Sakaida, Takuya Miyazaki, Katsuhiro Shono, Kota Yoshifuji, Shinichiro Machida, Takashi Toya, Noriko Doki, Satoru Takada, Kaoru Hatano, Jun Kato, Satoshi Takahashi, Jun Taguchi, Shingo Yano, Yoshinobu Kanda	0
3	Gene expression and TCR amino acid sequences selected by HLA‐A02:01‐restricted CTLs specific to HTLV‐1 in ATL patients 2023 ·British Journal of Haematology ·Machiko Kusuda, Hideki Nakasone, Kazuki Yoshimura, Yosuke Okada, Masaharu Tamaki, (unknown), (unknown), (unknown), (unknown), (unknown), Junko Takeshita, (unknown), (unknown), (unknown), Ayumi Gomyo, Aki Tanihara, Shun‐ichi Kimura, Shinichi Kako, Yoshinobu Kanda	0
4	Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation 2023 ·Scientific Reports ·Masaharu Tamaki, Yu Akahoshi, Masahiro Ashizawa, (unknown), (unknown), Sung‐Won Kim, Yukiyasu Ozawa, Shin‐ichiro Fujiwara, Shinichi Kako, Ken‐ichi Matsuoka, Masashi Sawa, Yuta Katayama, Makoto Onizuka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Kimikazu Yakushijin, Hideki Nakasone	3
5	Low-Intensity Immunosuppressive Therapy for Chronic Graft-versus-Host Disease 2022 ·Transplantation and Cellular Therapy ·Kazuki Yoshimura, Shun‐ichi Kimura, Hideki Nakasone, (unknown), (unknown), (unknown), Junko Takeshita, (unknown), (unknown), (unknown), Ayumi Gomyo, Aki Tanihara, Yosuke Okada, Masaharu Tamaki, Machiko Kusuda, Kazuaki Kameda, Hidenori Wada, Shinichi Kako, Yoshinobu Kanda	1
6	Dosimetric Evaluation of the Uterus in Patients Receiving Total Body Irradiation with Ovarian Shielding 2022 ·SHILAP Revista de lepidopterología ·(unknown), Shinichi Kako, Masato Suzuki, Yuta Takahashi, (unknown), Masahiro Kawahara, (unknown), (unknown), Satoru Takahashi, Yukiko Fukuda, (unknown), Noriko Oyama‐Manabe, Yoshinobu Kanda, Katsuyuki Shirai	1
7	Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation 2022 ·Bone Marrow Transplantation ·Yoshiko Atsuta, Junichi Sugita, Hirohisa Nakamae, Yumiko Maruyama, Ken Ishiyama, Souichi Shiratori, Takahiro Fukuda, Mio Kurata, Naoki Shingai, Yukiyasu Ozawa, Masayoshi Masuko, Koji Nagafuji, Satoru Takada, Shinichi Kako, Yoshinobu Kanda, Junya Kanda, Tatsuo Ichinohe, Takanori Teshima	9
8	Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI 2022 ·Hematological Oncology ·(unknown), Yasuyuki Arai, Tadakazu Kondo, Kaito Harada, Naoyuki Uchida, Takashi Toya, Yukiyasu Ozawa, Takahiro Fukuda, Shuichi Ota, Makoto Onizuka, Yoshinobu Kanda, Yumiko Maruyama, Satoru Takada, Toshiro Kawakita, Takahide Ara, Tatsuo Ichinohe, Takafumi Kimura, Yoshiko Atsuta, Shinichi Kako	2
9	Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type 2021 ·Clinical Cancer Research ·Takaaki Konuma, Junya Kanda, Yachiyo Kuwatsuka, Masamitsu Yanada, Tadakazu Kondo, Shigeki Hirabayashi, Shinichi Kako, Yu Akahoshi, Naoyuki Uchida, Noriko Doki, Yukiyasu Ozawa, Masatsugu Tanaka, Tetsuya Eto, Masashi Sawa, Satoshi Yoshioka, Takafumi Kimura, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Fumihiko Kimura	15
10	Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy‐refractory or relapsed disease prior to allogeneic stem cell transplantation 2021 ·British Journal of Haematology ·(unknown), Yasuyuki Arai, Shigeki Hirabayashi, Tadakazu Kondo, Noriko Doki, Naoyuki Uchida, Takahiro Fukuda, Yukiyasu Ozawa, Masatsugu Tanaka, Masashi Sawa, Yuta Katayama, Yoshinobu Kanda, Souichi Shiratori, Hirohisa Nakamae, Satoshi Yoshioka, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako	2
11	Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis 2021 ·Bone Marrow Transplantation ·Masamitsu Yanada, Shuichi Ota, (unknown), Miho Nara, Shinichi Kako, (unknown), Naoyuki Uchida, Masashi Sawa, Nobuaki Nakano, Makoto Onizuka, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shingo Yano	5
12	Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non‐relapse mortality after allogeneic hematopoietic stem cell transplantation 2021 ·Transplant Infectious Disease ·Junko Takeshita, Shun‐ichi Kimura, Hideki Nakasone, (unknown), (unknown), (unknown), (unknown), (unknown), Kazuki Yoshimura, (unknown), Ayumi Gomyo, Masaharu Tamaki, Yu Akahoshi, Machiko Kusuda, Kazuaki Kameda, (unknown), Miki Sato, Shinichi Kako, Yoshinobu Kanda	3
13	Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2 2021 ·Blood Advances ·Satoshi Nishiwaki, Yu Akahoshi, Shuichi Mizuta, Akihito Shinohara, Shigeki Hirabayashi, (unknown), Takahiro Fukuda, Naoyuki Uchida, Masatsugu Tanaka, Makoto Onizuka, Yukiyasu Ozawa, Shuichi Ota, Souichi Shiratori, Yasushi Onishi, Yoshinobu Kanda, Masashi Sawa, Junji Tanaka, Yoshiko Atsuta, Shinichi Kako	6
14	Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis 2021 ·Bone Marrow Transplantation ·Shuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, Yuho Najima, Takeshi Kobayashi, Yukiyasu Ozawa, Yoshinobu Kanda, Shinichi Kako, Toshiro Kawakita, Ken‐ichi Matsuoka, Yumiko Maruyama, Shuichi Ota, Hideyuki Nakazawa, Kazunori Imada, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Jun Aoki	5
15	Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine 2021 ·Cancer Science ·Yutaka Shimazu, Shohei Mizuno, Shin‐ichi Fuchida, Kazuhito Suzuki, Nobuhiro Tsukada, (unknown), (unknown), Keisuke Kataoka, Shinichi Kako, Emiko Sakaida, Satoshi Yoshioka, Shinsuke Iida, Noriko Doki, Tatsuo Oyake, Tatsuo Ichinohe, Yoshinobu Kanda, (unknown), Hiroyuki Takamatsu, (unknown)	11
16	Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission 2021 ·Bone Marrow Transplantation ·Takaaki Konuma, Tadakazu Kondo, Masayoshi Masuko, Hiroaki Shimizu, Souichi Shiratori, Takahiro Fukuda, Jun Kato, Masashi Sawa, Yukiyasu Ozawa, Shuichi Ota, Naoyuki Uchida, Yoshinobu Kanda, Shinichi Kako, Shin Fujisawa, Kentaro Fukushima, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada, (unknown)	9
17	Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype 2020 ·Bone Marrow Transplantation ·(unknown), Satoshi Kaito, Yuho Najima, Kaito Harada, Takahiro Fukuda, (unknown), Kazuhiro Ikegame, Masatsugu Tanaka, Yukiyasu Ozawa, Shuro Yoshida, Masashi Sawa, Shuichi Ota, (unknown), Junji Tanaka, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako	5
18	Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation 2020 ·Transplant Infectious Disease ·Shun‐ichi Kimura, (unknown), (unknown), Junko Takeshita, (unknown), (unknown), (unknown), Kazuki Yoshimura, (unknown), Ayumi Gomyo, Yu Akahoshi, Masaharu Tamaki, Machiko Kusuda, Kazuaki Kameda, (unknown), Miki Sato, Aki Tanihara, Hideki Nakasone, Shinichi Kako, Yoshinobu Kanda	3
19	Correlations of cytokine levels in cerebrospinal fluid and peripheral blood with outcome of HHV‐6B encephalitis after hematopoietic stem cell transplantation 2019 ·Transplant Infectious Disease ·Kuniko Takano, Masao Ogata, Takako Satou, Yasuhiko Miyazaki, (unknown), Noriyuki Saito, Toshimitsu Ueki, Shinichi Kako, Takahiro Fukuda, Kuniaki Shirao	4
20	Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study 2018 ·Blood ·Shinichi Kako, Yoshinobu Kanda, Makoto Onizuka, Nobuyuki Aotsuka, Kensuke Usuki, Takayoshi Tachibana, Takeshi Kobayashi, Jun Kato, Shingo Yano, Hiroaki Shimizu, Katsuhiro Shono, Masatsugu Tanaka, Shokichi Tsukamoto, Takehiko Mori, Etsuko Yamazaki, Shinichiro Okamoto	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact